Name
OÜ Kõneravi
Registry code
11056481
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.07.2004 (20)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86909 - Other healthcare activities not classified elsewhere
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| RIIN NAESTEMA 03.07.1974 (50) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| Kristjan Krass 17.10.1975 (48) | - | Board member | - |
| 2019 29.06.2020 | 2020 04.07.2021 | 2021 27.06.2022 | 2022 25.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 311 971 € | 355 677 € | 421 010 € | 520 332 € |
| Net profit (loss) for the period | 8 492 € | 20 755 € | 40 964 € | 55 425 € |
| Profit Margin | 3% | 6% | 10% | 11% |
| Current Assets | 50 405 € | 67 160 € | 109 687 € | 171 426 € |
| Fixed Assets | 18 920 € | 13 760 € | 10 467 € | 12 687 € |
| Total Assets | 69 325 € | 80 920 € | 120 154 € | 184 113 € |
| Current Liabilities | 24 415 € | 27 255 € | 37 805 € | 58 899 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 44 910 € | 53 665 € | 82 349 € | 125 214 € |
| Employees | 8 | 8 | 10 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 36 882.91 € | 39 936.72 € | 18 |
| 2023 Q4 | - | 34 887.1 € | 37 793.22 € | 18 |
| 2023 Q3 | - | 31 426.38 € | 31 605.3 € | 17 |
| 2023 Q2 | - | 29 899.21 € | 32 314.67 € | 15 |
| 2023 Q1 | - | 33 415.71 € | 36 146.7 € | 14 |
| 2022 Q4 | - | 34 043.68 € | 34 248.22 € | 15 |
| 2022 Q3 | - | 26 385.78 € | 28 558.86 € | 15 |
| 2022 Q2 | - | 24 243.02 € | 26 278.12 € | 14 |
| 2022 Q1 | - | 24 308.6 € | 26 437.83 € | 15 |
| 2021 Q4 | - | 25 227.49 € | 24 421.9 € | 15 |
| 2021 Q3 | - | 18 846.11 € | 20 476.37 € | 14 |
| 2021 Q2 | - | 17 782.2 € | 19 332.96 € | 13 |
| 2021 Q1 | - | 20 446.71 € | 22 215.72 € | 14 |
| 2020 Q4 | - | 19 196.91 € | 20 859.89 € | 15 |
| 2020 Q3 | - | 20 447.52 € | 18 930.57 € | 15 |
| 2020 Q2 | - | 20 900.68 € | 22 667.27 € | 15 |
| 2020 Q1 | - | 19 082.04 € | 20 697.75 € | 17 |
